We are live on ! Find out more
NLVP

New Leaf Venture Partners Portfolio holdings

AUM $43M
1-Year Est. Return 25.55%
This Fund
S&P 500
This Quarter Est. Return
+37.44%
1 Year Est. Return
-25.55%
3 Year Est. Return
+17.13%
5 Year Est. Return
+114.46%
10 Year Est. Return
+1,011.57%
AUM
$349M
AUM Growth
+$14.2M
Cap. Flow
-$66.4M
Cap. Flow %
-19.05%
Top 10 Hldgs %
93.07%
Holding
20
New
–
Increased
–
Reduced
4
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
+$46.9M
2
PRNB
Principia Biopharma Inc. Common Stock
PRNB
+$10.7M
3
ALEC icon
Alector
ALEC
+$8.28M
4
STIM icon
Neuronetics
STIM
+$526K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARVN icon
1
Arvinas
ARVN
$514M
$76.6M 21.97%
2,283,048
– –
DCPH
2
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$72.2M 20.73%
1,209,571
-877,152
-42% -$46.9M
PASG icon
3
Passage Bio
PASG
$15.8M
$68.3M 19.59%
124,896
– –
HARP
4
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$48.5M 13.92%
292,141
– –
PRNB
5
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
$14.9M 4.29%
249,774
-172,440
-41% -$10.7M
APTX
6
DELISTED
Aptinyx Inc. Common Stock
APTX
$13.7M 3.94%
3,290,079
– –
ARAV
7
DELISTED
Aravive, Inc. Common Stock
ARAV
$11M 3.16%
946,423
– –
ALEC icon
8
Alector
ALEC
$167M
$8.3M 2.38%
339,569
-300,000
-47% -$8.28M
TECX
9
Tectonic Therapeutic
TECX
$576M
$5.51M 1.58%
26,296
– –
OBSV
10
DELISTED
ObsEva SA Ordinary Shares
OBSV
$5.3M 1.52%
900,501
– –
SRRA
11
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$4.96M 1.42%
409,611
– –
CMRX
12
DELISTED
Chimerix, Inc.
CMRX
$4.18M 1.2%
1,350,000
– –
CHMA
13
DELISTED
Chiasma, Inc. Common Stock
CHMA
$3.96M 1.14%
735,700
– –
XFOR icon
14
X4 Pharmaceuticals
XFOR
$363M
$3.12M 0.9%
11,167
– –
CRNX icon
15
Crinetics Pharmaceuticals
CRNX
$8.86B
$2.47M 0.71%
141,000
– –
ITRM
16
DELISTED
Iterum Therapeutics
ITRM
$1.73M 0.5%
97,087
– –
NERV icon
17
Minerva Neurosciences
NERV
$191M
$1.62M 0.47%
56,188
– –
STIM icon
18
Neuronetics
STIM
$125M
$1.04M 0.3%
540,317
-256,368
-32% -$526K
COGT icon
19
Cogent Biosciences
COGT
$6.74B
$826K 0.24%
448,886
– –
PDSB icon
20
PDS Biotechnology
PDSB
$38M
$236K 0.07%
117,242
– –

Similar funds

BAM
Broadcrest Asset Management Winter Park, Florida $44.1M AUM 4.51% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
WCPI
Wynnchurch Capital Partners IV Rosemont, Illinois $44.8M AUM 11.91% 1-Year Est. Return
WAMC
Western Asset Management Company Pasadena, California $45.2M AUM 6.96% 1-Year Est. Return
CC
Corton Capital Carrying Place, Ontario, Canada $40.7M AUM 52.32% 1-Year Est. Return
CIEP
Constellation Investimentos e Participacoes Sao Paulo, Brazil $46.7M AUM 23.3% 1-Year Est. Return
IPI
Inflection Point Investments London, United Kingdom $46.9M AUM 18.35% 1-Year Est. Return
VSAM
Value Star Asset Management Hong Kong $49.2M AUM 60.1% 1-Year Est. Return

New Leaf Venture Partners's Q2 2020 Portfolio in Review

As of Q2 2020, New Leaf Venture Partners held 20 positions worth $349M, up 4.3% from $334M the previous quarter. Its ten largest holdings account for 93% of the portfolio.

New Leaf Venture Partners withdrew a net $66.4M in Q2 2020, reducing 4 holdings. Its largest reduction was Deciphera Pharmaceuticals, Inc. Common Stock, cutting an estimated $46.9M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • New Leaf Venture Partners's biggest Q2 2020 reduction was Deciphera Pharmaceuticals, Inc. Common Stock, cutting an estimated $46.9M.
  • New Leaf Venture Partners's ten largest holdings make up 93% of its $349M portfolio in Q2 2020.
  • New Leaf Venture Partners opened 0 new positions and closed 0 in Q2 2020.
  • New Leaf Venture Partners's portfolio value rose 4.3% quarter-over-quarter to $349M.

Based on New Leaf Venture Partners's 13F filing for Q2 2020, filed 13 Aug 2020.